Phase II clinical trial to determine if polyphenon E inhibits c-met signaling and activation of pathways contributing to breast cancer progression

Trial Profile

Phase II clinical trial to determine if polyphenon E inhibits c-met signaling and activation of pathways contributing to breast cancer progression

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Sep 2017

At a glance

  • Drugs Polyphenon E (Primary)
  • Indications Advanced breast cancer; Early breast cancer
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 23 Sep 2017 Status changed from active, no longer recruiting to completed.
    • 10 Jun 2017 Biomarkers information updated
    • 25 Oct 2012 Planned End Date changed from 1 Jul 2012 to 1 Jul 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top